NCT05364736Not yet recruiting
Effect of Prebiotics on Blood Pressure Management
An Interventional Study for the Effects of Highland Barley β-glucan on the Management of Hypertension and Cardiovascular Risk
Source: ClinicalTrials.gov · Last updated 6 May 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This survey is designed to investigate the effect of highland barley β-glucan supplementation on the regulatory of blood pressure, gut microbiota and cardiovascular risk fators in subjects with hypertention.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 3 May 2022
- Start date
- 17 Oct 2022
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Sun Yat-sen University
- Diseases
- High blood pressure
- NCT number
- NCT05364736
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 17 Oct 2022 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Receiving or have been treated with antihypertensive drugs.
- Complications including chronic gastrointestinal disease; or suffered from acute gastrointestinal diseases within 1 months before screening visit.
- Received antibiotics, probiotics within 3 months before screening visit or throughout the trail.
Other illness
- Complications including cardiovascular and cerebrovascular diseases such as coronary heart disease and stroke.
- Autoimmune diseases or thyroid diseases.
- Malignant disease, infectious disease, inflammatory disease and advanced liver disease.
Lab values
- Severe liver or renal insufficiency (alanine aminotransferase, aspartate aminotransferase or alkaline phosphatase is greater than 3 times the upper limit of normal OR GFR\<30ml/min/1.73m2).
Other
- Women who are pregnant, nursing, or prepare to give birth during the trail.
- Mental or intellectual abnormalities, unable to sign informed consent.
- Major operations were performed within six months of screening visit, or will be made during the trial.
- Alcohol abuse (alcohol intake\>60g/d for male and alcohol intake\>40g/d for female)
Who the study is looking for
- Age:30-65 years old
- Newly diagnosed hypertension did not use antihypertensive drugs OR Systolic blood pressure ≥140mmHg on the physical examination OR Diastolic blood pressure ≥90mmHg on the physical examination.
- BMI≥18 kg/m2
Age in the registry: 30 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sun Yat-sen University Coordinator of this site? Confirm its status | Guangzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.